Moventig vs Relistor: Side-by-Side Comparison
Quick answer: Moventig and Relistor are both peripherally-acting mu-opioid receptor antagonist (pamora) used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Moventig | Relistor |
|---|---|---|
| Drug class | Peripherally-acting mu-opioid receptor antagonist (PAMORA) | Peripherally-acting mu-opioid receptor antagonist (PAMORA) |
| ATC code | A06AH03 | A06AH01 |
| Primary indications | Opioid-induced constipation | Opioid-induced constipation |
| Mechanism | Naloxegol is a pegylated mu-opioid receptor antagonist that selectively blocks peripheral opioid receptors in the gut without crossing the blood-brain barrier | Peripherally-restricted mu-opioid receptor antagonist (methylnaltrexone) reversing opioid-induced gut effects without affecting analgesia |
| Common dose | 25 mg orally once daily | 8-12 mg SC every other day or 450 mg PO once daily |
| Detail page | Moventig details → | Relistor details → |
How to choose between Moventig and Relistor
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Peripherally-acting mu-opioid receptor antagonist (PAMORA) on iMedic · Moventig full details · Relistor full details
Frequently asked questions
Is Moventig better than Relistor?
Neither is universally 'better.' They are both peripherally-acting mu-opioid receptor antagonist (pamora) with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Moventig to Relistor?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Moventig and Relistor have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Moventig and Relistor available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.